FDA Approves New Breast Cancer Drug Perjeta

FDA OKs Perjeta for Late-Stage Breast Cancer New Drug Halts Disease Progression for an Average of 18.5 Months WebMD Medical News By Matt McMillen Reviewed by Louise Chang, MD More...

Click here to read the full story.

Post a Comment
 

Enter the words shown above Enter the numbers you hear
Refresh Image Audio Help
 
Comments
No comments yet!

The Health News section does not provide medical advice, diagnosis or treatment. See additional information.

Inergize Digital This site is hosted and managed by Inergize Digital.
Mobile advertising for this site is available on Local Ad Buy.